Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 4 , Pages 621-640 , December 2007

Inhibition of the protein tyrosine phosphatase PTP1B: potential therapy for obesity, insulin resistance and type-2 diabetes mellitus

  • Shlomit Koren, MD (Research Fellow, Internal Medicine and Endocrinology and Metabolism, Department of Medicine and Banting and Best Diabetes Center, University of Toronto)
  • I. George Fantus, MD, FRCP(C) (Professor, Department of Medicine and Physiology and Director, Division of Endocrinology and Metabolism, University of Toronto)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: 416 586 8665; Fax: 416 361 2657.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(07)00081-4

doi: 10.1016/j.beem.2007.08.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 4 , Pages 621-640 , December 2007

Article Tools

* Image Usage & Resolution